Pan MR - Search Results

1

Human nuclease/helicase DNA2 alleviates replication stress by promoting DNA end resection.

Peng G, Dai H, Zhang W, Hsieh HJ, Pan MR, Park YY, Tsai RY, Bedrosian I, Lee JS, Ira G, Lin SY. Peng G, et al. Among authors: pan mr. Cancer Res. 2012 Jun 1;72(11):2802-13. doi: 10.1158/0008-5472.CAN-11-3152. Epub 2012 Apr 9. Cancer Res. 2012. PMID: 22491672 Free PMC article.

2

BRIT1/MCPH1 links chromatin remodelling to DNA damage response.

Peng G, Yim EK, Dai H, Jackson AP, Burgt Iv, Pan MR, Hu R, Li K, Lin SY. Peng G, et al. Among authors: pan mr. Nat Cell Biol. 2009 Jul;11(7):865-72. doi: 10.1038/ncb1895. Epub 2009 Jun 14. Nat Cell Biol. 2009. PMID: 19525936 Free PMC article.

3

Monoubiquitination of H2AX protein regulates DNA damage response signaling.

Pan MR, Peng G, Hung WC, Lin SY. Pan MR, et al. J Biol Chem. 2011 Aug 12;286(32):28599-607. doi: 10.1074/jbc.M111.256297. Epub 2011 Jun 15. J Biol Chem. 2011. PMID: 21676867 Free PMC article.

4

Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.

Pan MR, Hsieh HJ, Dai H, Hung WC, Li K, Peng G, Lin SY. Pan MR, et al. J Biol Chem. 2012 Feb 24;287(9):6764-72. doi: 10.1074/jbc.M111.287037. Epub 2012 Jan 4. J Biol Chem. 2012. PMID: 22219182 Free PMC article.

5

Connecting the Dots: From DNA Damage and Repair to Aging.

Pan MR, Li K, Lin SY, Hung WC. Pan MR, et al. Int J Mol Sci. 2016 May 6;17(5):685. doi: 10.3390/ijms17050685. Int J Mol Sci. 2016. PMID: 27164092 Free PMC article. Review.

6

G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response.

Luo CW, Wang JY, Hung WC, Peng G, Tsai YL, Chang TM, Chai CY, Lin CH, Pan MR. Luo CW, et al. Among authors: pan mr. Radiother Oncol. 2017 Sep;124(3):395-402. doi: 10.1016/j.radonc.2017.03.002. Epub 2017 Mar 25. Radiother Oncol. 2017. PMID: 28351524

7

De-glycosylated membrane PD-L1 in tumor tissues as a biomarker for responsiveness to atezolizumab (Tecentriq) in advanced breast cancer patients.

Ou-Yang F, Li CL, Chen CC, Shen YC, Moi SH, Luo CW, Xia WY, Wang YN, Lee HH, Wang LH, Wang SC, Pan MR, Hou MF, Hung MC. Ou-Yang F, et al. Among authors: pan mr. Am J Cancer Res. 2022 Jan 15;12(1):123-137. eCollection 2022. Am J Cancer Res. 2022. PMID: 35141008 Free PMC article.

8

Increased blood CSF3R⁺ myeloid-derived suppressor cell is a predictor for breast cancer recurrence.

Li YL, Chen CH, Lai YS, Pan MR, Hung WC. Li YL, et al. Among authors: pan mr. Am J Cancer Res. 2024 Jun 25;14(6):3171-3185. doi: 10.62347/MUKD2745. eCollection 2024. Am J Cancer Res. 2024. PMID: 39005677 Free PMC article.

9

The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.

Hou MF, Luo CW, Chang TM, Hung WC, Chen TY, Tsai YL, Chai CY, Pan MR. Hou MF, et al. Among authors: pan mr. Exp Cell Res. 2017 Oct 15;359(2):458-465. doi: 10.1016/j.yexcr.2017.08.029. Epub 2017 Aug 24. Exp Cell Res. 2017. PMID: 28842166

10

Impact of BMI1 expression on the apoptotic effect of paclitaxel in colorectal cancer.

Tsai HL, Pang SY, Wang HC, Luo CW, Li QL, Chen TY, Fang SY, Wang JY, Pan MR. Tsai HL, et al. Among authors: pan mr. Am J Cancer Res. 2019 Nov 1;9(11):2544-2553. eCollection 2019. Am J Cancer Res. 2019. PMID: 31815052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters